252 related articles for article (PubMed ID: 16786771)
21. Spot urine albumin to creatinine ratio and serum cystatin C are effective for detection of diabetic nephropathy in childhood diabetic patients.
Chae HW; Shin JI; Kwon AR; Kim HS; Kim DH
J Korean Med Sci; 2012 Jul; 27(7):784-7. PubMed ID: 22787375
[TBL] [Abstract][Full Text] [Related]
22. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients.
Uslu S; Efe B; Alataş O; Kebapçi N; Colak O; Demirüstü C; Yörük A
J Nephrol; 2005; 18(5):559-67. PubMed ID: 16299682
[TBL] [Abstract][Full Text] [Related]
23. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.
Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME
J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858
[TBL] [Abstract][Full Text] [Related]
24. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.
Rosolowsky ET; Ficociello LH; Maselli NJ; Niewczas MA; Binns AL; Roshan B; Warram JH; Krolewski AS
Clin J Am Soc Nephrol; 2008 May; 3(3):706-13. PubMed ID: 18272826
[TBL] [Abstract][Full Text] [Related]
25. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
[TBL] [Abstract][Full Text] [Related]
26. [Cardiovascular risk factors in diabetic nephropathy].
Zimmermann J; Schramm L; Mulzer E; Heidbreder E; Henrich HA; Wanner C
Med Klin (Munich); 1997 Feb; 92(2):74-8. PubMed ID: 9139214
[TBL] [Abstract][Full Text] [Related]
27. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.
Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M
Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752
[TBL] [Abstract][Full Text] [Related]
28. Early commitment of cardiovascular autonomic modulation in Brazilian patients with congenital generalized lipodystrophy.
Ponte CMM; Fernandes VO; Gurgel MHC; Vasconcelos ITGF; Karbage LBAS; Liberato CBR; Negrato CA; Gomes MB; Montenegro APDR; Montenegro Júnior RM
BMC Cardiovasc Disord; 2018 Jan; 18(1):6. PubMed ID: 29329523
[TBL] [Abstract][Full Text] [Related]
29. Altered blood pressure profile, autonomic neuropathy and nephropathy in insulin-dependent diabetic patients.
Monteagudo PT; Nóbrega JC; Cezarini PR; Ferreira SR; Kohlmann O; Ribeiro AB; Zanella MT
Eur J Endocrinol; 1996 Dec; 135(6):683-8. PubMed ID: 9025713
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors.
Stella P; Ellis D; Maser RE; Orchard TJ
J Diabetes Complications; 2000; 14(1):1-6. PubMed ID: 10925059
[TBL] [Abstract][Full Text] [Related]
31. Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress.
Perkins BA; Krolewski AS
Curr Diab Rep; 2005 Dec; 5(6):455-63. PubMed ID: 16316598
[TBL] [Abstract][Full Text] [Related]
32. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance.
Tan GD; Lewis AV; James TJ; Altmann P; Taylor RP; Levy JC
Diabetes Care; 2002 Nov; 25(11):2004-9. PubMed ID: 12401747
[TBL] [Abstract][Full Text] [Related]
33. The 10-year incidence of renal insufficiency in people with type 1 diabetes.
Klein R; Klein BE; Moss SE; Cruickshanks KJ; Brazy PC
Diabetes Care; 1999 May; 22(5):743-51. PubMed ID: 10332675
[TBL] [Abstract][Full Text] [Related]
34. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
Peczyńska J; Urban M; Głowińska B; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
[TBL] [Abstract][Full Text] [Related]
35. Plasma cystatin C concentration in non-insulin-dependent diabetes mellitus: relation with nephropathy.
Piwowar A; Knapik-Kordecka M; Buczyńska H; Warwas M
Arch Immunol Ther Exp (Warsz); 1999; 47(5):327-31. PubMed ID: 10604239
[TBL] [Abstract][Full Text] [Related]
36. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
[TBL] [Abstract][Full Text] [Related]
37. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
[TBL] [Abstract][Full Text] [Related]
38. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
39. Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications.
Sherif EM; El Maksood AAA; Youssef OI; Salah El-Din NY; Khater OKM
J Diabetes Complications; 2019 Sep; 33(9):628-633. PubMed ID: 31301955
[TBL] [Abstract][Full Text] [Related]
40. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.
Hadjadj S; Duly-Bouhanick B; Bekherraz A; BrIdoux F; Gallois Y; Mauco G; Ebran J; Marre M
Diabetes Metab; 2004 Feb; 30(1):43-51. PubMed ID: 15029097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
